Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES Share Price    (DIVI)

Here is the latest stock price and chart of DIVIS LABORATORIES. For more details, see the DIVIS LABORATORIES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.

Watch Now: One Stock Crorepati Replay is Available Now

REFRESH
Live BSE Quotes Jul 1, 2022 03:31:00 PM
Price (Rs)3,644.00 Open (Rs) 3,595.00 High (Rs) 3,647.75 Low (Rs) 3,581.35
% Change0.36 Volume 6,796 Value (Rs) 24,764,624 52-Week H/L 5,425.00 / 3,365.10
Live NSE Quotes Jul 1, 2022 3:29:59 PM
Price (Rs)3,647.00 Open (Rs) 3,590.35 High (Rs) 3,649.60 Low (Rs) 3,581.05
% Change0.46 Volume 304,382 Value (Rs) 1,099,920,883 52-Week H/L 5,425.10 / 3,365.55
Change
1 Day
0.36%
1 Month
2.47%
3 Months
-16.80%
1 Year
-17.84%
5 Years (CAGR)*
40.31%
10 Years (CAGR)*
13.32%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 111.52 P/E Ratio (x) 32.68 Market Cap (Rs m) 967,367.58 P/BV (x) 8.22 Dividend Yield (%) 0.55
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

DIVIS LABORATORIES Share Price Today:

DIVIS LABORATORIES last traded price was up 0.4% to Rs 3,644.0 on the BSE. On the NSE, DIVIS LABORATORIES last traded price was up 0.5% to Rs 3,647.0. The total volume of shares traded was 0.3 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.6%. And the benchmark S&P BSE SENSEX was at 52,907.9 (down 0.2%).

Over the last 30 days, the DIVIS LABORATORIES share price is up 2.1%. And over the last one year, DIVIS LABORATORIES share price is down 16.4%.

The current market capitalisation of DIVIS LABORATORIES stands at Rs 967,367.58 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of March 2022, company promoters held 51.94% stake in DIVIS LABORATORIES, with no shares having been pledged. To know more, check out the latest shareholding pattern of DIVIS LABORATORIES.


What else is happening in the markets today? Dig in...


FAQs on DIVIS LABORATORIES

What is the DIVIS LABORATORIES share price today?

The last traded price of DIVIS LABORATORIES was Rs 3,644.0 on the BSE, up 0.4% over the previous close. On the NSE, DIVIS LABORATORIES last traded price was up 0.5% at Rs 3,647.0.

What is the market cap of DIVIS LABORATORIES?

The current market capitalisation of DIVIS LABORATORIES stands at Rs 967,368 m. For more information, check out the list of top 100 companies in India in terms of market cap.

What is the Earnings per share (EPS) of DIVIS LABORATORIES?

DIVIS LABORATORIES had an EPS of Rs 111.5 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs 33.7.

What is the PE Ratio and PB Ratio of DIVIS LABORATORIES?

At the current price of Rs 3,644.0, DIVIS LABORATORIES trades at a PE ratio of 32.68 while its PB ratio stands at 8.22.

What is the Dividend Yield of DIVIS LABORATORIES?

For the financial year 2021, DIVIS LABORATORIES declared dividend amounting to Rs 20.0 per share. At the current price of Rs 3,644.0, this results in a dividend yield of 0.5%.


Today's Market

Sensex Ends 111 Points Lower, Nifty Holds 15,750; ONGC, Reliance Crash, while ITC & Bajaj Twins Gain 4%(Closing)

After opening the day deep in the red, Indian share markets slowly recovered most of their losses and ended on a flat note.

Related Views On News

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

How to Find the Next Multibagger Stock in the Market (Profit Hunter)

Jun 17, 2022

The #1 make or break factor in your portfolio you shouldn't ignore.

Is the Market Correction Over? (Fast Profits Daily)

Jun 17, 2022

In this video I'll show you why I think the market correction could be coming to an end.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - KREBS BIOCHEMICALS COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS